Meridiem Investment Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-800
Closed -$227K 61
2024
Q1
$227K Sell
800
-381
-32% -$111K ﹤0.01% 40
2023
Q4
$340K Buy
+1,181
New +$322K 0.01% 40

Other funds holding AMGN

Meridiem Investment Management's AMGN Position: Q2 2024 in Review

Meridiem Investment Management sold out of Amgen (AMGN) in Q2 2024, closing a stake of 800 shares — an estimated $227K sold.

Meridiem Investment Management first reported a position in AMGN in Q4 2023 and held it in 2 quarters. The position peaked at $340K in Q4 2023. 2,785 funds tracked by Wall St. Rank hold AMGN as of Q2 2024.

  • Meridiem Investment Management reported no remaining Amgen position as of Q2 2024 after selling out during the quarter.
  • Meridiem Investment Management sold 800 Amgen shares in Q2 2024, an estimated $227K.
  • Meridiem Investment Management first reported a position in Amgen in Q4 2023 and held it in 2 quarters.
  • Meridiem Investment Management's Amgen position peaked at $340K in Q4 2023.
  • 2,785 funds tracked by Wall St. Rank held Amgen as of Q2 2024.

Based on Meridiem Investment Management's 13F filing for Q2 2024, filed 14 Aug 2024.